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To identify unknown human viruses in the enteric tract, 
we examined 105 stool specimens from patients with diar-
rhea in Bangladesh. A novel calicivirus was identiﬁ  ed in a 
sample from 1 patient and subsequently found in samples 
from 5 other patients. Phylogenetic analyses classiﬁ  ed this 
virus within the proposed genus Recovirus. 
D
iarrhea, characterized by frequent liquid or loose 
stools, commonly results from gastroenteritis caused 
by infection with bacteria, parasites, or viruses. Patients 
with mild diarrhea do not require medical attention; the ill-
ness is typically self-limited, and disease symptoms usually 
resolve quickly. However, diarrheal diseases can result in 
severe illness and death worldwide and are the second lead-
ing cause of death around the world in children <5 years of 
age, particularly in low- and middle-income countries (1). 
For many cases of diarrhea in humans, no causative agent 
is identiﬁ  ed.  
In recent years, many novel viruses have been identi-
ﬁ  ed in human and animal blood, respiratory secretions, and 
fecal material through viral metagenomic studies consist-
ing of random ampliﬁ  cation in combination with next-gen-
eration sequencing methods (2–5). To identify unknown 
human viruses in the enteric tracts of persons with diarrhea, 
we performed sequence-independent ampliﬁ  cation on puri-
ﬁ  ed viral nucleic acid from fecal samples obtained from 
patients with diarrhea in Bangladesh (6,7). We identiﬁ  ed 
a novel calicivirus and classiﬁ  ed it in the proposed genus 
Recovirus. Caliciviruses, which are nonenveloped, posi-
tive-stranded RNA viruses with a polyadenylated genome 
οf ≈6.4–8.4 kb, cause illness in animals and humans (8,9), 
including gastroenteritis in humans. The family Caliciviri-
dae consists of 5 genera, Norovirus, Sapovirus, Lagovirus, 
Vesivirus, and Nebovirus, and 3 proposed genera, Recovi-
rus, Valovirus, and chicken calicivirus (8–10).
The Study
Each year, >100,000 diarrhea patients are admitted to 
the Dhaka hospital of the International Centre for Diarrheal 
Disease Research, Bangladesh (ICDDR,B). Fecal samples 
from 2% of these patients are collected and examined as part 
of systematic routine surveillance system for the presence 
of enteric pathogens (11). All procedures were performed in 
compliance with relevant laws and institutional guidelines 
and in accordance with the Declaration of Helsinki. 
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Figure 1. Schematic outline of the strategies used for PCR 
ampliﬁ   cation of calicivirus Bangladesh/289/2007. A) Schematic 
representation of the calicivirus Bangladesh/289/2007 genome. 
Boxes represent the open reading frames encoding the calicivirus 
proteins. Indicated are the poly(A)-tail (An); putative cleavage 
sites indicated by XX↓XX. The 5′ end of the genome was not 
obtained. The bottom of the panel shows a schematic outline of 
the reverse transcription PCRs employed to amplify calicivirus 
Bangladesh/289/2007 sequences by using random ampliﬁ  cation, 
degenerate PCR, and 3′ rapid ampliﬁ  cation of cDNA ends (RACE) 
PCR. The orientations and positions of the oligonucleotides on the 
calicivirus genome are depicted and sequences shown in online 
Technical Appendix Table 2 (wwwnc.cdc.gov/EID/pdfs/12-0344-
Techapp.pdf). B) Genome organization of caliciviruses in the 
genera Vesivirus, Nebovirus, Norovirus, Sapovirus, and Lagovirus 
and proposed genera Valovirus and Recovirus, for comparison 
with the new calicivirus Bangladesh/289/2007. The 5′ end of the 
genome is shown with a Vpg protein (black dots). Numbers indicate 
the nucleotide positions according to the virus genome for which 
the GenBank accession number is indicated.Calicivirus, Bangladesh
Stool specimens from a subset of patients from rou-
tine surveillance during 2007–2009 (1,614 samples total) 
were available for further studies. These specimens were 
prescreened for adenovirus and rotavirus A by using Taq-
Man EZ RT-PCR Core Reagents (Applied Biosystems, 
Foster City, CA, USA), rotavirus primers RVNSP3R and 
RVNSP3F and probe 5′-FAM-AGTTAAAAGCTAA-
CACTGTCAAA-TAMRA-3′ ( 12), and TaqMan Univer-
sal Mastermix (Applied Biosystems) (13). Sequence-in-
dependent nucleic acid ampliﬁ  cation and next-generation 
sequencing were performed on 105 stool specimens from 
diarrhea patients enrolled during 2007 by using a 454 GS 
Junior Instrument (Roche, Indianapolis, IN, USA) as de-
scribed (6,7). More than 725,000 trimmed reads were 
assembled by using de novo assembly and analyzed ac-
cording to BLAST searches (online Technical Appendix 
Figure 1 and Table 1, wwwnc.cdc.gov/EID/pdfs/12-0344-
Techapp.pdf) (6,7). Sequences were classiﬁ  ed on the basis 
of the taxonomic origin of the best-hit sequence (6,7). An 
E (expect) value of 0.001 was used as cutoff value of sig-
niﬁ  cant virus hits. The largest proportion of virus-related 
sequences in human diarrhea samples from Bangladesh in 
2007 was related to known bacteriophages and mammalian 
viruses (online Technical Appendix Figure 1).
One sample, no. 289, yielded a novel mammalian vi-
rus from the family Caliciviridae that we further character-
ized by near full-length genome sequencing using random 
ampliﬁ   cation with next-generation sequencing, speciﬁ  c 
reverse transcription PCRs, and 3′ rapid ampliﬁ  cation of 
cDNA ends PCR (Figure 1, panel A) as described (6,7). We 
named the virus isolate calicivirus Bangladesh/289/2007 
(GenBank accession no. JQ745645). 
The Caliciviridae genome encodes a polyprotein pre-
cursor for nonstructural proteins, and 2 structural capsid 
proteins, viral protein (VP) 1 and VP2, from 2 or 3 open 
reading frames (ORFs) (Figure 1, panel B) (8,9). The ge-
nome organization of Bangladesh/289/2007 is most closely 
related to that of viruses in the genus Norovirus, with ORF2 
encoding VP1 overlapping with ORF1 (Figure 1). The par-
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Table 1. Percentage amino acid identity of calicivirus Bangladesh/289/2007 with representative caliciviruses of other genera* 
Calicivirus genus  Strain  GenBank accession no.  NS polyprotein†  VP1  VP2 
Norovirus  Norwalk M87661  27.7  30.4  24.7 
Southampton L07418  29.0  31.2  23.3 
Sapovirus Manchester X86560  20.1 18.6  4.1 
PEC Cowden  AF182760  18.3  18.1  6.8 
Vesivirus  FCV CFI68  U13992  18.4  16.3  15.1 
SMSV 1  U15301  19.0  19.3  5.5 
Lagovirus RHDV FRG  M67473  18.0  19.6  9.6 
EBHSV GD  Z69620  17.3  17.8  5.5 
Nebovirus BEC NB  AY082891  18.7  16.8  11.0 
 Newbury  1  DQ013304  19.0  16.8  11.0 
Recovirus‡ Tulane  EU391643  57.7  49.5  53.1 
Valovirus‡ AB104  FJ355930  35.8  43.5  26.0 
*NS, nonstructural; VP, viral protein. 
†All polyprotein sequences were aligned without the capsid protein encoding sequences. 
‡Tentative genus not yet accepted by the International Committee on Taxonomy of Viruses. 
Figure 2. Neighbor-joining phylogenetic trees of the amino 
acid sequences of the partial polyprotein sequence (A), viral 
protein (VP) 1 (B), and VP2 (C) capsid proteins of selected 
representative caliciviruses and the newly identiﬁ  ed  Recovirus 
Bangladesh/289/2007 (indicated in boldface). Phylograms 
were generated by using MEGA5 (www.megasoftware.net) with 
p-distance and 1,000 bootstrap replicates. Signiﬁ  cant  bootstrap 
values and GenBank accession numbers are shown. Scale bars 
indicate amino acid substitutions per site. tial polyprotein precursor and complete VP1 and VP2 pro-
teins were aligned with corresponding sequences of repre-
sentative caliciviruses. Divergence analysis demonstrated 
that the calicivirus Bangladesh/289/2007 showed 57.7%, 
49.5%, and 53.1% amino acid identity in the polyprotein, 
VP1, and VP2, respectively, to its closest relative, Recovi-
rus Tulane (GenBank accession no. EU391643), which was 
identiﬁ  ed from rhesus macaques (Table 1; Figure 2). 
Additionally, on the basis of the identity proﬁ  les of 
noroviruses (14)—strains, genotypes, and genogroups 
showed 85.9%–100%, 56.2%–85.7%, and 38.6%–55.1% 
identity, respectively—Bangladesh/289/2007 may repre-
sent a new genogroup in the proposed genus Recovirus. 
This conclusion was corroborated by comparison of a par-
tial RNA-dependent RNA polymerase (RdRp) sequence of 
calicivirus Bangladesh/289/2007 to known recovirus RdRp 
sequences (online Technical Appendix Figure 2).
We performed a diagnostic real-time recovirus PCR 
targeting the RdRp of all 1,614 available samples from pa-
tients with diarrhea (11). Reverse transcription PCR–grade 
viral nucleic acid was extracted by using the MagNA Pure 
LC Total Nucleic Acid Isolation Kit (Roche) and ampliﬁ  ed 
by using reverse transcription PCR with primers VS665 
and VS666 and probe VS664 (online Technical Appendix 
Table 2) and TaqMan EZ RT-PCR Core Reagents (Applied 
Biosystems). The cycling program consisted of 50°C for 
2 min, 60°C for 30 min, 95°C for 5 min, and 50 cycles of 
95°C for 20 s and 59°C for 1 min, resulting in a 164-bp 
amplicon. 
In addition to sample 289, 5 other human diarrhea 
samples (Table 2) were sequence-conﬁ  rmed to be positive 
for a recovirus, with high homology (>98%) to calicivirus 
Bangladesh/289/2007; this ﬁ  nding indicates that recovi-
rus Bangladesh infects humans. Clinical data indicate that 
all patients with a recovirus present in their feces had 6 to 
>21 watery stools in the ﬁ  rst 24 hours after illness onset 
(Table 2); 4 patients experienced vomiting and 2 patients 
had fever. Patient ages ranged from 3 months to 50 years. 
Three recovirus-positive patients showed evidence of co-
infection with other pathogens that are known to cause di-
arrhea in humans, such as rotavirus A, adenovirus, Vibrio 
cholerae, or Salmonella spp.; the other 3 patients did not. 
Although viruses such as norovirus, sapovirus, and astro-
virus were not detected in the recovirus-positive samples 
by sequence-independent ampliﬁ  cation assays, all samples 
were not analyzed for all known enteric pathogens. Of 514 
diarrhea samples gathered by the Diagnostic Unit, Depart-
ment of Virology, Erasmus Medical Center, Rotterdam, 
the Netherlands, for diagnosis of gastrointestinal infections 
during 2007 and 2009, none was positive for Recovirus 
Bangladesh (data not shown).
Conclusions
For a large proportion of human diarrhea cases, no 
etiologic agent can be identiﬁ  ed, despite multiple metage-
nomic studies of viruses in human stool aimed at identify-
ing new etiologic agents (3–5). In addition, it cannot be 
known when and where emerging and reemerging viruses 
will appear in the human population. To identify poten-
tial etiologic agents of diarrhea in humans, we performed 
a metagenomic viral inventory in diarrhea samples from 
Bangladesh, which led to the identiﬁ  cation of a novel cali-
civirus. 
Although no species demarcation criteria have been 
deﬁ  ned for the family Caliciviridae by the International 
Committee on the Taxonomy of Viruses, we classiﬁ  ed 
calicivirus Bangladesh/289/2007 in the proposed genus 
Recovirus, primarily on the basis of phylogenetic analyses 
(8). Bangladesh/289/2007 may also be considered a new 
genogroup of the genus Recovirus for the following rea-
sons: 1) the genetic distance between Recovirus Tulane and 
Bangladesh/289/2007 VP1 is similar to that of VP1 capsids 
of noroviruses belonging to different genogroups (14); 2) 
the genetic distances between macaque recoviruses and 
Recovirus Bangladesh/289/2007 RdRP are similar to that 
of RdRP sequences of recoviruses belonging to different 
genogroups (15); 3) the genome organization of Recovirus 
Tulane and Bangladesh/289/2007 differs; and 4) Recovirus 
Tulane and Bangladesh/289/2007 were identiﬁ  ed in differ-
ent host species. 
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condition Other  pathogens‡ 
201  23/M  2007  Yes <1  11–15 <10 Yes  Lethargic  None 
289§ 25/M  2007  No  <1  6–10  <10  Yes  Lethargic  None 
445 20/M  2007  No  1–3  11–15  0  Yes  Normal  None 
507  50/F  2007  No <1  6–10 <10 No  Drowsy  Vibrio cholerae 
809 0/M  2008  No  4–6  >21  <10  No Lethargic  Rotavirus  A 
1084 1/M  2008  Yes  1–3  6–10  0  Yes  Normal  Adenovirus/ 
Salmonella spp. 
*All patients had watery diarrhea. 
†Number of events in 24 h before sample collection. 
‡The pathogens that were tested for were Shigella spp., Aeromonas spp., Vibrio cholerae, Campylobacter spp., and Salmonella spp. In addition, the 
samples were screened for Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Ascaris lumbricoides, Cyclospora cayetanensis, Isospora belli,
adenoviruses, and group A rotaviruses. 
§The virus from patient 289 is the initially described calicivirus Bangladesh/289/2007 from this study. Calicivirus, Bangladesh
In conclusion, this identiﬁ  cation of a novel calicivirus, 
classiﬁ  ed as Recovirus Bangladesh/289/2007, from human 
diarrhea samples provides PCR-based evidence that reco-
viruses can infect humans. A previous study found high 
prevalence of virus-neutralizing antibodies against a close-
ly related calicivirus, Recovirus Tulane, in serum samples 
from animal caretakers (15). Larger epidemiologic studies 
using genetic and serologic screening will be necessary to 
provide more insight into the distribution and pathogenic 
potential of recoviruses in humans.  
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